Investor profile
Novalis LifeSciences has backed 2 European tech companies across 2 funding rounds in 2022, joining rounds totalling €127M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Ori Biotech | UK | 1 | €88M |
| eTheRNA | Belgium | 1 | €39M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Ori Biotech | Series B | €88M | 2022-01 |
| eTheRNA | Series B | €39M | 2022-08 |
